Phreesia (PHR) Net Equity Issued and Repurchased (2020 - 2021)

Phreesia (PHR) reported Net Equity Issued and Repurchased of $245.8 million for Q2 2021, up 40.63% sequentially from $174.8 million in Q4 2020.

Phreesia (PHR) Net Equity Issued and Repurchased (2020 - 2021) Analysis & Trends

Phreesia (PHR) has 2 years of Net Equity Issued and Repurchased data on file, last reported at $245.8 million in Q2 2021.

  • For the quarter ending Q2 2021, Net Equity Issued and Repurchased changed N/A year-over-year to $245.8 million; the trailing twelve-month figure through Jan 2022 stood at $245.8 million (up 40.63% YoY), and the FY2022 full-year result was $245.8 million, up 40.63% from the prior year.
  • Net Equity Issued and Repurchased grew to $245.8 million in Q2 2021, from $174.8 million in the prior quarter.
  • In the past five years, Net Equity Issued and Repurchased ranged from a high of $245.8 million in Q2 2021 to a low of $174.8 million in Q4 2020.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Equity Issued and Repurchased (Qtr)
1 Veeva Systems 31.81 Bn 24.49 Bn 662.02 Mn -
2 BrightSpring Health Services 14.76 Bn 13.86 Bn 482.22 Mn -
3 Healthequity 8.36 Bn 8.10 Bn 256.31 Mn -
4 Hinge Health 5.91 Bn 5.60 Bn 154.23 Mn -
5 10x Genomics 5.89 Bn 5.35 Bn 106.18 Mn -
6 MiniMed 4.45 Bn 4.16 Bn 480.00 Mn -
7 Waystar Holding 4.41 Bn 4.35 Bn 216.84 Mn -
8 Doximity 3.93 Bn 3.18 Bn 125.97 Mn -
9 Privia Health 3.10 Bn 2.68 Bn - -
10 Phreesia 651.50 Mn 575.10 Mn 113.28 Mn -

Historic Data

Download Data
DateValue
Apr 30, 2021 245.81 Mn
Apr 30, 2021 245.81 Mn
Oct 31, 2020 174.80 Mn
Oct 31, 2020 174.80 Mn